News & Insights

SolentimNews & Insights
Conferences duncanb

Solentim to exhibit at BioProcess International, September 20-23, Boston

Solentim, the trusted global leader in workflows for antibody and cell-based therapies, will be exhibiting at the BioProcess International, September 20-23, Boston. Come visit stand #435 where we’ll be presenting our integrated ecosystem of technologies for seeding, assurance, growth and selection. BioProcess International is billed as the the largest bioprocessing event for learning how to …

Read more Solentim to exhibit at BioProcess International, September 20-23, Boston

Product teodorapopovici

STUDIUS™ – A Gamechanger for Cell Line Development: New Commentary White Paper

Operating within the structure of Chemical, Manufacturing and Control (CMC), Cell Line Development (CLD) is a pivotal control strategy within the development of therapeutic antibodies. Risk-based strategies towards quality control are deeply embedded in CLD yet challenged, as are CLD scientists, on a daily basis with the burden and worry of data consolidation. Methodologies, utilised …

Read more STUDIUS™ – A Gamechanger for Cell Line Development: New Commentary White Paper

Corporate sciadseo

Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market

Bournemouth, UK, 10th June 2021 / Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, has today announced an exclusive distribution agreement with Matrixome Inc. (Japan) for use in conjunction with Solentim’s instrumentation. Under the new agreement, Solentim will add a clinical manufacturing-grade …

Read more Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market

Product teodorapopovici

NEW! iPSC Virtual Demo Hub | A tour of our labs and technology

Enjoy a new 15 minute virtual demonstration from within Solentim’s laboratories and download resources to learn how our new workflow for iPSC seeding can help you overcome challenges associated with iPSC workflows. iPSCs have practically an unlimited proliferation potential, and a capability to differentiate into any cell type in the human body. Because of this, …

Read more NEW! iPSC Virtual Demo Hub | A tour of our labs and technology

Conferences sciadseo

Connect with Solentim at ISSCR

Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is delighted to announce that it will be presenting and exhibiting at the ISSCR 2021 Annual Meeting, taking place virtually, 21-26 June 2021. Dr Ian Taylor, Chief Business Officer, Solentim will present …

Read more Connect with Solentim at ISSCR

Product teodorapopovici

A vision of a Cell Line Development Ecosystem: New White Paper

Cell Line Development (CLD) is a required process within therapeutic antibody development, a journey made by single high value cells, through growth, selection and ultimately to cell banking. Decision making at each step requires information derived from different technologies, traditionally disparate, unconnected platforms. Understanding and managing the quality of this data and moreover, following the data …

Read more A vision of a Cell Line Development Ecosystem: New White Paper